TR199701520T1 - Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu. - Google Patents
Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu.Info
- Publication number
- TR199701520T1 TR199701520T1 TR97/01520T TR9701520T TR199701520T1 TR 199701520 T1 TR199701520 T1 TR 199701520T1 TR 97/01520 T TR97/01520 T TR 97/01520T TR 9701520 T TR9701520 T TR 9701520T TR 199701520 T1 TR199701520 T1 TR 199701520T1
- Authority
- TR
- Turkey
- Prior art keywords
- pain relief
- cell lineage
- analgesic compounds
- produces analgesic
- produces
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 150000003943 catecholamines Chemical class 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48191795A | 1995-06-07 | 1995-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199701520T1 true TR199701520T1 (xx) | 1998-04-21 |
Family
ID=23913905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR97/01520T TR199701520T1 (xx) | 1995-06-07 | 1996-06-07 | Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0833935A1 (de) |
| JP (1) | JPH11507530A (de) |
| KR (1) | KR19990022414A (de) |
| CN (1) | CN1192246A (de) |
| AR (1) | AR004494A1 (de) |
| AU (1) | AU6263696A (de) |
| BR (1) | BR9608746A (de) |
| CA (1) | CA2223246A1 (de) |
| CZ (1) | CZ392497A3 (de) |
| EE (1) | EE9700326A (de) |
| HU (1) | HUP9901191A2 (de) |
| IL (1) | IL122415A0 (de) |
| IN (1) | IN181898B (de) |
| IS (1) | IS4628A (de) |
| NO (1) | NO975545L (de) |
| PL (1) | PL323867A1 (de) |
| SK (1) | SK167997A3 (de) |
| TR (1) | TR199701520T1 (de) |
| WO (1) | WO1996040959A1 (de) |
| ZA (1) | ZA964880B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU751811B2 (en) * | 1997-11-28 | 2002-08-29 | Medical Research Council | Vectors |
| WO2000016799A1 (en) * | 1998-09-23 | 2000-03-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of treating chronic pain |
| US6372489B1 (en) | 1998-10-27 | 2002-04-16 | Anticancer, Inc. | Method and model for hair pigmentation |
| AU1324100A (en) * | 1998-10-27 | 2000-05-15 | Anticancer, Inc. | Method and model for hair pigmentation |
| US6903244B1 (en) | 1999-02-26 | 2005-06-07 | University Of Utah Research Foundation | Mice which are +/− or −/− for the elastin gene as models for vascular disease |
| AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
| JP2007516984A (ja) | 2003-12-24 | 2007-06-28 | ザ ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ | 治療用物質およびそのための用途 |
| CA2566549C (en) | 2004-05-12 | 2014-01-14 | The Walter And Eliza Hall Institute Of Medical Research | A method for isolating mammary stem cells |
| DK2407484T3 (en) | 2005-06-24 | 2016-09-05 | The Walter And Eliza Hall Inst Of Medical Res | Therapeutic pro-apoptotic BH3-like molecules, and methods of generating and / or selecting those |
| EP2051726B1 (de) | 2006-07-18 | 2018-04-18 | University of Utah Research Foundation | Verfahren zur behandlung von schmerzen und screening von analgetischen verbindungen |
| US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
| CA2913993A1 (en) | 2013-05-31 | 2014-12-04 | University Of Utah Research Foundation | Conotoxin peptides, pharmaceutical compositions and uses thereof |
| EP3368551B1 (de) | 2015-10-27 | 2023-07-12 | The University Of Queensland | Ein modifiziertes epha4-polypeptid |
| CN107964047B (zh) * | 2017-12-18 | 2018-11-02 | 哈尔滨工业大学 | 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用 |
| CN112891337A (zh) * | 2021-03-26 | 2021-06-04 | 河北医科大学 | 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE218893T1 (de) * | 1993-08-12 | 2002-06-15 | Neurotech Sa | Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten |
-
1996
- 1996-06-05 IN IN1039CA1996 patent/IN181898B/en unknown
- 1996-06-06 AR ARP960102993A patent/AR004494A1/es unknown
- 1996-06-07 PL PL96323867A patent/PL323867A1/xx unknown
- 1996-06-07 EP EP96921403A patent/EP0833935A1/de not_active Withdrawn
- 1996-06-07 CN CN96195750A patent/CN1192246A/zh active Pending
- 1996-06-07 CA CA002223246A patent/CA2223246A1/en not_active Abandoned
- 1996-06-07 IL IL12241596A patent/IL122415A0/xx unknown
- 1996-06-07 CZ CZ973924A patent/CZ392497A3/cs unknown
- 1996-06-07 JP JP9501908A patent/JPH11507530A/ja active Pending
- 1996-06-07 WO PCT/US1996/009629 patent/WO1996040959A1/en not_active Application Discontinuation
- 1996-06-07 SK SK1679-97A patent/SK167997A3/sk unknown
- 1996-06-07 KR KR1019970708894A patent/KR19990022414A/ko not_active Application Discontinuation
- 1996-06-07 ZA ZA964880A patent/ZA964880B/xx unknown
- 1996-06-07 TR TR97/01520T patent/TR199701520T1/xx unknown
- 1996-06-07 AU AU62636/96A patent/AU6263696A/en not_active Abandoned
- 1996-06-07 HU HU9901191A patent/HUP9901191A2/hu unknown
- 1996-06-07 EE EE9700326A patent/EE9700326A/xx unknown
- 1996-06-07 BR BR9608746A patent/BR9608746A/pt unknown
-
1997
- 1997-12-02 NO NO975545A patent/NO975545L/no unknown
- 1997-12-04 IS IS4628A patent/IS4628A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO975545D0 (no) | 1997-12-02 |
| JPH11507530A (ja) | 1999-07-06 |
| CN1192246A (zh) | 1998-09-02 |
| NO975545L (no) | 1998-02-04 |
| AR004494A1 (es) | 1998-12-16 |
| EP0833935A1 (de) | 1998-04-08 |
| AU6263696A (en) | 1996-12-30 |
| BR9608746A (pt) | 1999-05-11 |
| WO1996040959A1 (en) | 1996-12-19 |
| HUP9901191A2 (hu) | 1999-08-30 |
| IN181898B (de) | 1998-10-24 |
| IS4628A (is) | 1997-12-04 |
| ZA964880B (en) | 1997-01-07 |
| SK167997A3 (en) | 1998-05-06 |
| PL323867A1 (en) | 1998-04-27 |
| KR19990022414A (ko) | 1999-03-25 |
| IL122415A0 (en) | 1998-06-15 |
| CZ392497A3 (cs) | 1998-12-16 |
| CA2223246A1 (en) | 1996-12-19 |
| EE9700326A (et) | 1998-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199701520T1 (xx) | Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu. | |
| BR0015110A (pt) | Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos | |
| ATE168560T1 (de) | Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins | |
| EP0946147A4 (de) | Behandlung der pferdelahmheit | |
| IL138979A0 (en) | Use of cannabinoids as anti-inflammatory agents | |
| DE69735848D1 (de) | Dosisform mit ansteigender dosisfreisetzung | |
| HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
| TR199800644T2 (xx) | Bir apoptoz inhibit�r� olarak y-RAR antagonist ligand� ya da alfa-RAR antagonist ligand�. | |
| AU3139097A (en) | Methods of preventing skeletal problems in poultry | |
| HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
| HK1033910A1 (en) | Use of erythropoietin in the treatment of multiple myeloma | |
| ATE526944T1 (de) | Selbstbräunungszusammensetzungen die cholesterolsulfat und dha enthalten | |
| DE69633396D1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
| DE69634662D1 (de) | Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester | |
| NO984760L (no) | Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon | |
| TR199903074T2 (xx) | Kanser tedavisinde HMG CoA ve farnesil transfer �nleyicileri. | |
| DE69626816D1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
| ZA986720B (en) | Photoresponsive sunscreen compositions | |
| MD1569G2 (ro) | Metodă de tratament al cancerului mamar în perioada preoperatorie | |
| TR200102576T2 (tr) | Kanser tedavisinde radyoaktif sisplatin | |
| IT1290910B1 (it) | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive | |
| DE69906701D1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
| MD916G2 (ro) | Unguent pentru tratamentul afecţiunilor dentare | |
| IL126157A0 (en) | Method for treating excessive aggression | |
| MX9709828A (es) | Linea celular que produce compuestos analgesicos para el tratamiento del dolor. |